Literature DB >> 18405707

Perinatal profile of ventricular overload markers in congenital diaphragmatic hernia.

Maria João Baptista1, Cristina Nogueira-Silva, José Carlos Areias, Jorge Correia-Pinto.   

Abstract

BACKGROUND: In congenital diaphragmatic hernia (CDH), pulmonary hypertension increases right ventricle (RV) afterload, which could impair heart function and contribute to poor outcome for most affected infants. Nevertheless, the real significance of vascular pulmonary alterations in perinatal hemodynamics is largely unknown. It is defined that ventricular pressure overload induces increased myocardium gene expression of B-type natriuretic peptide (BNP) and components of the renin-angiotensinogen and endothelin (ET)-1 systems. Our aim was to evaluate perinatal myocardium expression of these genes associated with ventricular pressure overload in a nitrofen-induced CDH rat model.
METHODS: In the nitrofen-induced CDH rat model, fetuses from dated pregnant Sprague-Dawley rats at 15.5, 17.5, 19.5 and 21.5 days postcoitum as well as newborn pups were assigned to 3 experimental groups: control, nitrofen (exposed to nitrofen, without CDH), and CDH (exposed to nitrofen, with CDH). Myocardial samples collected from the RV and left ventricle (LV) were processed for quantification of messenger RNA (mRNA) of BNP, angiotensinogen, and ET-1.
RESULTS: The perinatal expression of BNP, angiotensinogen, and ET-1 mRNA in the RV and LV of the control group revealed daily changes. During gestation, the expression of BNP and angiotensinogen mRNA underwent significant oscillation compared with control in both nitrofen-exposed fetuses, although we cannot identify significant differences between the nitrofen and CDH groups. After birth, we found a significant increasing expression of all studied genes only in the RV of CDH pups.
CONCLUSIONS: Perinatal myocardial quantification of BNP, angiotensinogen, and ET-1 mRNA levels suggests that both nitrofen-exposed and control pups revealed prenatal variations of expression of the studied genes. Moreover, CDH is associated with significant molecular alterations only in the RV after birth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18405707     DOI: 10.1016/j.jpedsurg.2007.08.044

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

Review 1.  Plasma B-type natriuretic peptides in children with cardiovascular diseases.

Authors:  Bibhuti B Das
Journal:  Pediatr Cardiol       Date:  2010-10-07       Impact factor: 1.655

2.  Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia.

Authors:  Cristina Nogueira-Silva; Emanuel Carvalho-Dias; Paulina Piairo; Susana Nunes; Maria J Baptista; Rute S Moura; Jorge Correia-Pinto
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  Antenatal BAY 41-2272 reduces pulmonary hypertension in the rabbit model of congenital diaphragmatic hernia.

Authors:  Aline Vuckovic; Susanne Herber-Jonat; Andreas W Flemmer; Brigitte Strizek; Alexander C Engels; Jacques C Jani
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-12       Impact factor: 5.464

4.  Mid-term differences in right ventricular function in patients with congenital diaphragmatic hernia compared with controls.

Authors:  Matthew J Egan; Nazia Husain; Jack R Stines; Nasser Moiduddin; Melanie A Stein; Leif D Nelin; Clifford L Cua
Journal:  World J Pediatr       Date:  2012-11-15       Impact factor: 2.764

5.  Heart of the Matter? Early Ventricular Dysfunction in Congenital Diaphragmatic Hernia.

Authors:  David G Tingay; John P Kinsella
Journal:  Am J Respir Crit Care Med       Date:  2019-12-15       Impact factor: 21.405

Review 6.  The heart in congenital diaphragmatic hernia: Knowns, unknowns, and future priorities.

Authors:  Neil Patel; Anna C Massolo; Ulrike S Kraemer; Florian Kipfmueller
Journal:  Front Pediatr       Date:  2022-08-16       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.